NEU 15.7% $23.97 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-179

  1. 5,722 Posts.
    lightbulb Created with Sketch. 272


    An aquirer will likely have many other parts. So the exposure for Neurens assets would be highly diluted if a current shareholder invested in the aquirer.

    Thus it would`t be effective. IMO

    Best to get the maximum possible when/if TO occurs. Not good enough offer, send `em packing.

    It will really depend if there is more than 1 suitor.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$23.97
Change
3.260(15.7%)
Mkt cap ! $3.060B
Open High Low Value Volume
$23.00 $24.00 $21.60 $27.11M 1.181M

Buyers (Bids)

No. Vol. Price($)
2 942 $23.95
 

Sellers (Offers)

Price($) Vol. No.
$23.97 27 1
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
$24.00
  Change
3.260 ( 16.0 %)
Open High Low Volume
$22.98 $24.00 $21.60 310545
Last updated 15.59pm 27/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.